MOR-201

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameMOR-201
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionFibroblast growth factors antagonists
TargetsFibroblast growth factors
Therapy Area/IndicationsHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMorphosys AgProchon Biotech Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMorphosys Ag
Active IndicationsN/A
Inactive IndicationsHematologic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A